Treating Alcohol Dependence - Home | California Society of
Download
Report
Transcript Treating Alcohol Dependence - Home | California Society of
Treatment of Alcoholism
and Addiction
Steven R. Ey, M.D.
Medical Director
Genesis Chemical Dependency Unit
South Coast Medical Center
Laguna Beach, CA
April 14, 2005
Addiction Reward Pathway
Admission Labs
Labs (BAL, CBC, Chem 22, Mg, TSH, RPR,
lipase, UDS, UA, pregnancy test)
PPD
CXR
EKG
Acetaminophen and salicilate level as
indicated
Absorption and Metabolism
Sites include stomach, small intestine, and colon
Dependent on gastric emptying time
Metabolized primarily in the liver by oxidation
Alcohol dehydrogenase exhibits zero-order kinetics
(15 mg/dl/hr)
Proportional to body weight
Microsomal ethanol oxidizing system (MEOS)
Alcohol inhibits cytochrome P-450
Alcohol Breakdown
Alcohol
ADH
Acetaldehyde
ALDH
Acetic acid and water
Alcohol Intoxication
20-99mg% loss of muscular coordination,
change in behavior
100-199mg% ataxia, mental impairment
200-299mg% obvious intoxication, nausea
and vomiting
300-399mg% severe dysarthria and amnesia
Alcohol Intoxication cont.
400-600mg% coma occurs
600-800mg% decreased respirations and
blood pressure, obtundation, often fatal
Important to remember the role of tolerance
in all these categories
Management of Alcohol
Intoxication
Cardiovascular and respiratory support to control
blood pressure and maintain airway
Intravenous fluids (“Banana Bag-NS, thiamine,
MVI, Folate, B-12)
Assess for other drug use especially benzo’s or
opioids as antagonists can be used
Closely monitor until withdrawal begins and then
start treatment
Monitoring Alcohol
Withdrawal
MSSA (Modified Selective Severity
Assessment)
CIWA-A (Clinical Institute Withdrawal
Assessment for Alcohol)
Advantage for personnel to monitor progress
and treat accordingly
Disadvantage is cookbook approach
Withdrawal Signs and
Symptoms
Tremor
Agitation
Autonomic changes (BP, HR, Temp.)
Seizures
Sensorium changes (eg, hallucinations,
confusion)
Withdrawal Syndrome Stage 1
Begins within 24 hours
Lasts up to 5 days
90% of cases do not go beyond stage 1
Other symptoms include depressed mood,
anxiety, diaphoresis, headache,
nausea/vomiting, etc.
Withdrawal Syndrome Stage 2
Mostly untreated or undertreated in stage 1
Same signs and symptoms in stage 1 only
more severe
Hallmark is hallucinations (generally
perceived as benign)
Usually occurs 48 hours after last drink
Withdrawal Syndrome Stage 3
Usually occurs 72 hours after last drink
Delirium Tremens (acute reversible organic
psychosis) has 2% mortality
Lacks insight into hallucination, often
disoriented and labile
Seen in persons with severe alcoholism
and/or significant medical problems
Detoxification Treatment
Begin benzodiazepine at onset of withdrawal
symptoms
Be cautious that symptoms are withdrawal
and not intoxication
If uncertain repeat BAC to be sure it is
decreasing before sedating detoxification
meds are instituted
Detox Pharmacology
Benzodiazepine and Barbiturate equivalents:
Diazepam 10mg
Lorazepam 2mg
Phenobarbital 30mg
Chlordiazepoxide 25mg
Oxazepam 30mg
Detox Pharmacotherapy
Know 2-3 drugs well for routine detox (e.g.,
Diazepam 10-20 mg Q1 hr prn withdrawal)
Magnesium sulfate 2 gm for severe withdrawal
(esp. in seizure risk)
Daily thiamine 100 mg, folate 1mg, and MVI
Push fluids
Supportive therapy (eg hypertension meds, etc.)
Stage 3 withdrawal usually requires iv fluids, foley
catheter, soft restraints, etc.
Alcohol Withdrawal Seizures
More common in untreated alcoholics
Should hospitalize if first seizure
Need to be evaluated for other causes (eg, head
injury, CVA, or CNS infection, etc.) if first seizure
or history not clear
Work up includes brain imaging and EEG
1 in 4 patients have a second seizure within 6-12
hours
Must report any seizure to County Health Dept. and
inform patient not to drive
Alcohol Withdrawal Seizures
Mostly Grand mal seizures
Usually 24-48 hours after last drink but may
be within 8 hours
BAC does not have to be zero
Less than 3% become status epilepticus
Increased risk if prior seizure or detoxing off
sedative hypnotic as well
GABA and NMDA Neuronal
Receptors
Substance Abuse, J Lowinson, MD.
Third Edition, 1997, page 129.
Kindling and Seizures
Alcohol Withdrawal Seizure
Treatment
Parenteral benzodiazepines (eg, ativan 2 mg or
valium 10 mg iv stat)
Seizure precautions
Valium 10-20 mg q1 hour prn or scheduled taper
Anti-convulsants are generally not indicated unless
the diagnosis is in doubt
Work up if 1st seizure
Report to County Health Dept. and no driving until
cleared
Pharmacotherapy Treatment
Disulfiram
Naltrexone
Acamprosate
Disulfiram
Deterrent therapy
Inhibits metabolism of alcohol by blocking
acetaldehyde dehydrogenase
Acetaldehyde is toxic product causing the reaction
(flushed, tachycardia, diaphoresis, nausea,
headache, etc.)
Metronidazole and alcohol may cause disulfiram
like reaction
Disulfiram (cont.)
Prescribing tips (read the label for alcohol if
not sure)
Monitor liver enzymes
May cause psychosis
Evaluate need for patient to take in front of
staff
Naltrexone
Opiate blocker
Evidence for reduced cravings and relapse
rates
23% relapsed vs. 54% placebo during 12
week study
Definition of relapse
Volpicelli, 1992
Naltrexone cont.
VA study Dec 13, 2001 NEJM
627 veterans given 12 mo Naltrexone, or 3
mo. Naltrexone and 9 mo placebo, or 12 mo
placebo
No statistically significant difference in #
days to relapse at 13 weeks, and no
difference in % days drinking at 52 weeks
Krystal, et al. NEJM Volume 345, pg.
1734-39, Dec 13, 2001
Acamprosate
Affinity for GABA A and GABA B receptors
Inhibits glutamate effect on NMDA receptors
Now available in the United States
Acamprosate cont.
Multiple studies in Europe show it effectiveness
and safety
Tempesta, et al. (2000) found abstinence rate 57.9%
with acamprosate versus 45.2% with placebo
Sass, et al. (1996) found at the end of 48 weeks of
treatment and 48 more weeks of follow-up that 39%
of the acamprosate group vs. 17% of the placebo
group remained abstinent
Case Scenario #1
40 y.o. male admitted with BAC 460 mg/dl.
Communicates clearly
History of recent Alcohol Withdrawal
Seizure
History of multiple AMA’s during detox in
the past
Case Scenario #1 Treatment
Patient has high tolerance so medicate appropriately
Monitor closely and repeat BAC to ensure it is
decreasing
May use Librium 100 mg po or Phenobarbital 130
mg im to decrease risk of seizure
Start valium 10-20 mg q 1 hour prn (or Ativan)
Begin thiamine 100 mg, folate 1 mg, & MVI daily
2 gm MgSO4 if withdrawal difficult or Mg low
Consider Depakote or Dilantin but not necessary
Case Scenario #2
55 y.o. female drinking 1 bottle wine per day
and taking xanax 4 mg. per day
Smokes 1 pack per day cigarettes
Complains of hip pain, fell 1 week ago
Case Scenario #2 Treatment
Alcohol detox with usual meds or Phenobarbital
Slow klonopin taper as outpatient is one option but
there are more (eg anti-seizure meds and quick
taper in hospital) to detox off of Xanax
Smoking cessation program
Don’t forget to check the hip pain.
Case Scenario #3
30 y.o. female drinking 1-2 bottles of wine
per day
History of Bulimia nervosa, last binge/purge
3 months ago
History of multiple relapses
Case Scenario #3 Treatment
Pregnancy test positive!
OB/GYN consult but you can order an
ultrasound now
Always treat as if they will keep the baby
Detox med of choice is Phenobarbital
Extended care in dual diagnosis program
Opioid Dependence
Physiologic dependence versus addiction
Common opioids
Rx drugs on the streets, etc.
Abuse patterns
Opioid Withdrawal Signs
COWS Scale
Elevated HR & BP, diaphoresis, restlessness,
pupil size, bone or joint aches, runny nose or
tearing, GI upset, tremor, yawning, anxiety
or irritability, gooseflesh skin
Score items stage to withdrawal
Opioid Treatment
Clonidine 0.1 mg every 2 hours prn
Benzodiazepine or barbiturate prn (eg,
Phenobarbital 15-30 mg every 3 hours prn)
NSAID
Muscle relaxant (eg, methacarbamol)
Bentyl for abdominal cramps
Sleeping agent (eg, temazepam)
Opioid Treatment (cont.)
Subutex (buprenorphine)
Suboxone (buprenorphine/naloxone)
Sublingual administration of partial opioid
agonist
Must be certified through DEA to use
Treatment with Suboxone
Certification requires ASAM, Addiction
Psychiatry, or 8 hour training course
Capacity to provide or to refer patients for
necessary ancillary services
Treat no more than 30 patients at one time
Opioid Case #1
45 y.o. female taking increasing doses of
hydrocodone per day
Currently on 90 mg per day
Repeatedly calling office, loses prescriptions
No pain etiology to explain use of narcotics
Opioid Case #1 Treatment
Recommend inpatient detox in CD program
Consider outpatient detox only in reliable,
motivated patient
Clonidine 0.1 mg q 2 hrs. prn, NSAID,
Muscle relaxant, bentyl, benzo’s for anxiety
and insomnia
Most CD programs using suboxone now
Sedative/Hypnotic Dependence
Difficult to detox
Seizure prophylaxis important
Rebound anxiety needs to be treated
Methods to obtain meds include legitimate
prescriptions, prescription fraud, multiple
MD’s or clinics, internet, foreign countries
and the street
Sedative/Hypnotic Treatment
Taper as outpatient 10% of dose per week as
outpatient
Quick taper as inpatient with anti-seizure
meds
Consider valproic acid or other anti-seizure
med for equivalent doses of valium 30 mg.
per day or more (based on clinical
experience)
Sedative/Hypnotic Case #1
32 yo male taking xanax for 3 years
Began with xanax 0.5 mg. BID
Now taking 6 mg. per day for 3 months
Also on SSRI
No history of seizure
Sed/Hyp Case #1 Treatment
Equivalent dose of valium 60 mg. per day
Likely to have seizure if stops abruptly
Recommend inpatient detox
Start valproic acid 250 mg. QID, keep on
therapeutic dose minimum 6 weeks
Substitute benzo or barb with limited doses for 5-7
days
Consider zyprexa or equivalent
Continue SSRI
Psychostimulants
Detox not a covered benefit
Medical complications usually bring patient
to ER
May admit for workup of Chest pain, CVA,
seizure, etc.
Referral to program
Nicotine
Fagerstrom Test
Nicotine Replacement (gum, patches)
Bupropion
Support Groups